John David Finley - 03 Jan 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director, Director
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
03 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Jan 2024, 16:00:30 UTC
Previous filing
19 Dec 2023
Next filing
01 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +1,309 +2.1% $0.000000 64,649 03 Jan 2024 Direct F1
holding PALI Common Stock, par value $0.01 777 03 Jan 2024 By FCW Investments, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -1,309 -100% 0 03 Jan 2024 Common Stock 1,309 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units.
F2 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F3 This restricted stock unit was granted on January 3, 2023 and 1,309 restricted stock units subject to the award vested on January 3, 2024. There are no additional restricted stock units underlying this grant.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.